Johns Hopkins Medicine Johns Hopkins Logo
make a gift
hopkins urology on you tube  twitter urology department at hopkins   facebook urology department at hopkins  blog urology department at hopkins  
                
   
Christian Pavlovich, M.D. Christian P. Pavlovich, M.D.
Associate Professor of Urology
Johns Hopkins Medical Institutions
Director, Urologic Oncology
Johns Hopkins Bayview Medical Center
Director, Urologic Oncology Fellowship
Johns Hopkins Medical Institutions

Email:cpavlov2@jhmi.edu

Dr. Pavlovich came to Johns Hopkins after completing a Urologic Oncology fellowship at the National Cancer Institute. His practice is dedicated primarily to the treatment of prostate, kidney and bladder cancer, as well as to the treatment of benign prostatic diseases. He is experienced in open, laparoscopic, and robotic minimally invasive surgery for the management of urologic tumors, including nerve-sparing laparoscopic and robot- assisted radical prostatectomy, laparoscopic and robotic nephrectomy and partial nephrectomy, and robotic radical cystectomy.

A particular expertise of his is the robotic extraperitoneal (or retroperitoneal) approach to the prostate and kidney for patients with prostate or kidney cancer. This approach, which avoids entry into the abdominal cavity, is ideally suited for patients that have had prior abdominal or inguinal operations (e.g. hernia repairs, appendectomy, colectomy) or who have inflammatory conditions (e.g. Crohn’s disease, ulcerative colitis, diverticulitis) that might make an abdominal robotic approach more hazardous.

Dr. Pavlovich’s research has been funded by the National Institutes of Health, Department of Defense, industry, and through institutional grants.  He continues to work  on early detection and risk stratification of prostate and kidney cancer using novel noninvasive urinary, blood, and imaging tests. As Director of Urologic Oncology at Johns Hopkins Bayview Medical Center, he continues to treat cancer with an emphasis on minimizing morbidity and maximizing quality of life, while exposing his patients to the latest treatment options and techniques. In addition, as Fellowship Director of Urologic Oncology for the Brady Urological Institute, he oversees the selection and training of the next generation of leaders in the field.

Dr. Pavlovich is accepting new patients and is delighted to offer second opinions regarding the treatment of any urologic malignancy.

EDUCATION & TRAINING

1987 A.B. Biology, cum laude Harvard University, Cambridge, MA
1992 Certificate, Molecular Biology, Université de Genève Switzerland
1993 M.D. University of California, San Francisco, CA

GRADUATE TRAINING


1993-95 Intern and Resident General Surgery New York Hospital - Cornell Medical Center, New York, NY
1995-98 Resident Urology New York Hospital - Cornell Medical Center, New York, NY
1998-99 Chief Resident Urology New York Hospital - Cornell Medical
Center, New York, NY


POSTGRADUATE TRAINING


1999-2001    Urologic Oncology National Cancer Institute, NIH, Bethesda, MD

 

LICENSURE & CERTIFICATION

  • Licensure - State of Maryland since 2001

  • Medical Boards - NBME Certified 1994

  • Specialty Boards -Board Certified in Urology 2003; recertified in 2013

PUBLICATIONS

Free Access to abstracts at PubMed

  Peer-reviewed scientific articles:

  1. Pavlovich CP, Schlegel PN. Fertility options after vasectomy: A cost-effectiveness analysis. Fertility and Sterility 1997; 67(1): 133-141.
  2. Schlegel PN, Pavlovich CP. Male infertility treatment options: A cost-effectiveness analysis. J Clin Outcomes Med 1997; 4 (6): 27-32.
  3. Kavolius JP, Mastorakos DP, Pavlovich CP, Russo P, Burt ME, Brady MS. Resection of metastatic renal cell carcinoma. J Clin Oncol 1998; 16 (6): 2261-2266.
  4. Poppas DP, Pavlovich CP, Folkman J, Voest EE, Chen X, Luster AD, and O’Donnell MA. Intravesical BCG induces the anti-angiogenic chemokine IP-10. Urology 1998; 52 (2): 268-276.
  5. Pavlovich CP, Gmyrek GA, Gardner TA, Poppas DP, Mininberg DT. Flexible transinguinal laparoscopy to assess the contralateral ring in pediatric inguinal hernias. Tech Urol 1998; 4 (3): 141-144.
  6. Ravizzini PI, Shulsinger D, Guarnizo E, Pavlovich CP, Marion D, Sosa RE. Hand-assisted laparoscopic donor nephrectomy versus standard laparoscopic donor nephrectomy: a comparison study in the canine model. Tech Urol1999; 5 (3): 174-178.
  7. Guarnizo EG, Pavlovich CP, Seiba M, Carlson DL, Vaughan ED Jr., Sosa RE. Ureteroscopic biopsy of upper tract urothelial carcinoma: improved diagnostic accuracy and histopathologic considerations using a multi-biopsy approach. J Urol 2000; 163: 52-55.
  8. Pavlovich CP, Kräling BM, Stewart RJ, Bochner BH, Chen X, Luster AD, Poppas DP, O’Donnell MA. BCG-induced urinary cytokines inhibit microvascular endothelial cell proliferation. J Urol 2000;163 (6): 2014-21.
  9. Terrence K, Pavlovich CP*, Matechak EO, Fowlkes BJ. Premature expression of TCR suppresses TCR gene rearrangement but permits development of lineage T cells. J Exp Med 2000; 192 (4): 1-13. *joint first authorship
  10. Choyke PL, Pavlovich CP, Daryanni K, Hewitt SM, Linehan WM, Walther MM. Intraoperative ultrasound during renal parenchymal sparing surgery for hereditary renal cancers: a 10-year experience. J Urol 2001; 165: 397-400.
  11. Pavlovich CP, King P, Goldstein M, Schlegel PN. Evidence of a treatable endocrinopathy in infertile men. J Urol 2001; 165: 837-841.
  12. Schmidt LS, Warren MB, Nickerson ML, Weirich G, Matrosova V, Toro JR, Turner ML, Duray P, Merino M, Hewitt S, Pavlovich CP, Glenn G, Greenberg CR, Linehan WM, Zbar B. Birt-Hogg-Dubé syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. Am J Hum Genet 2001; 69(4): 876-82.
  13. Pautler SE, Pavlovich CP, Mikityansky I, Drachenberg DE, Choyke PL, Linehan WM, Wood BJ, Walther MM. Retroperitoneoscopic-guided radiofrequency ablation of renal tumors. Can J Urol 2001; 8(4): 1330-3.
  14. Phillips JL, Hayward SW, Wang, Y, Vasselli J, Pavlovich CP, Padilla-Nash H, Pezullo JR, Ghadimi BM, Grossfeld GD, Rivera A, Linehan WM, Cunha GR, Ried T. The consequences of chromosomal aneuploidy on gene expression profiles in a cell line model for prostate carcinogenesis. Cancer Res 2001; 61(22): 8143-9.
  15. Pavlovich CP, Walther MM, Choyke PL, Pautler SE, Chang R, Linehan WM, Wood BJ. Percutaneous radiofrequency ablation of small renal tumors: Initial results. J Urol 2002; 167: 10-15.
  16. Zbar B, Alvord WG, Glenn G, Turner M, Toro J, Pavlovich CP, Merino M, Linehan WM. Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. Cancer Epidemiol Biomarkers Prev 2002; 11(4): 393-400.
  17. Nickerson ML, Warren MB, Toro JR, Matrosova V, Glenn G, Turner ML, Duray P, Merino M, Choyke P, Pavlovich CP, Sharma N, Walther M, Munroe D, Hill R, Maher E, Greenberg C, Lerman MI, Linehan WM, Zbar B, Schmidt LS. Mutations in a novel gene lead to kidney tumors, lung wall defects and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. Cancer Cell 2002; 2(2):157-164.
  18. Pautler SE, Choyke PL, Pavlovich CP, Daryanani K, Walther MM. Intraoperative ultrasound aids in dissection during laparoscopic partial adrenalectomy. J Urol 2002; 168(4 Pt 1):1352-5.
  19. Hwang JJ, Uchio EM, Pavlovich CP, Pautler SE, Libutti SK, Linehan WM, Walther MM. Surgical management of multi-organ visceral tumors in patients with von Hippel-Lindau disease: a single stage approach. J Urol 2003; 169: 895-8.
  20. Bhayani SB, Pavlovich CP, Hsu TS, Sullivan W, Su LM. Prospective Comparison of Short Term Convalescence: Laparoscopic Radical Prostatectomy versus Open Radical Prostatectomy. Urology 2003; 61: 612-616.
  21. Pavlovich CP, Linehan WM, Eyler R, Walther MM, Zbar B, Hewitt SE, Merino MJ. Renal tumors in the Birt-Hogg-Dubé syndrome. Am J Surg Path 2002; 26: 1542-52.
  22. Pavlovich CP, Padilla-Nash H, Wangsa D, Nickerson ML, Matrosova V, Linehan WM, Ried T, Phillips JL. Patterns of aneuploidy in advanced renal cell carcinoma. Genes Chromosomes Cancer 2003; 37(3): 252-60.
  23. Gonzalgo ML, Pavlovich CP, Lee SM, Nelson WG. Prostate cancer detection by GSTP1 methylation analysis of post-biopsy urine specimens. Clin Cancer Res 2003; 9(7): 2673-7.
  24. Bhayani SB, Pavlovich CP, Strup SE, Dahl, DM, Landman J, Fabrizio MD, Sundaram CP, Kaouk J, and Su LM. Laparoscopic radical prostatectomy: a multi-institutional study of conversion to open surgery. Urology 2004; 63, 99-102.
  25. Link RE, Su LM, Bhayani SB, Pavlovich CP. Making ends meet: a cost comparison of laparoscopic and open radical retropubic prostatectomy. J Urol 2004; 172: 269-74.
  26. Bhayani SB, Pavlovich CP, Su LM. Use of a specialized prostatic urethral sound to facilitate nerve-sparing laparoscopic radical prostatectomy. J Endourol 2004; 18: 289-291.
  27. Su LM, Link RE, Bhayani SB, Sullivan W, Pavlovich CP. Nerve-sparing laparoscopic radical prostatectomy: replicating the open surgical technique.
    Urology 2004; 64:123-7.
  28. Rogers CG, Yan G, Zha S, Gonzalgo ML, Isaacs WB, Luo J, DeMarzo AM, Nelson WG, Pavlovich CP. Prostate cancer detection by urinalysis for alpha methylacyl CoA racemase protein. J Urol 2004; 172:1501-1503.
  29. Gonzalgo ML, Yan G, Rogers CG, Nelson WG, Pavlovich CP. Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis. Clin Cancer Res 2004; 10: 7276-83.
  30. Link RE, Su LM, Sullivan W, Bhayani SB, Pavlovich CP. Health related quality of life before and after laparoscopic radical prostatectomy. J Urol 2005; 173: 175-179.
  31. Pavlovich CP, Grubb RL 3rd*, Hurley K, Glenn GM, Toro J, Schmidt LS, Torres-Cabala C, Merino MJ, Zbar B, Choyke P, Walther MM, Linehan WM. Evaluation and Management of Renal Tumors in the Birt-Hogg-Dubé Syndrome. J Urol 2005; 173:1482-1486. *joint first authorship
  32. Gonzalgo ML, Pavlovich CP, Trock BJ, Link RE, Sullivan W, Su L-M. Classification and trends of perioperative morbidities following laparoscopic radical prostatectomy. J Urol 2005; 174:135-9.
  33. Wagner A, Link R, Pavlovich C, Sullivan W, Su L. Use of a validated quality of life questionnaire to assess sexual function following laparoscopic radical prostatectomy. Int J Impot Res 2006; 18 (1): 69-76.
  34. Vocke CD, Yang Y, Pavlovich CP, Schmidt LS, Nickerson ML, Torres-Cabala CA, Merino MJ, Walther MM, Zbar B, Linehan WM. High Frequency of Somatic Frameshift BHD Gene Mutations in Birt-Hogg-Dubé-Associated Renal Tumors. J Natl Cancer Inst 2005; 97(12):931-5.
  35. Markushin Y, Gaikwad N, Zhang H, Kapke P, Rogan EG, Cavalieri EL, Trock BJ, Pavlovich C, Jankowiak R. Potential biomarker for early risk assessment of prostate cancer. Prostate 2006; 66(14): 1565-71.
  36. Rogers CG, Gonzalgo ML, Yan G, Bastian PJ, Chan DY, Nelson WG, Pavlovich CP. High concordance of gene methylation in post-digital rectal examination and post-biopsy urine samples for prostate cancer detection. J Urol 2006; 176 (5): 2280-2284.
  37. Rogers CG, Su LM, Link RE, Sullivan W, Wagner A, Pavlovich CP. Age-stratified functional outcomes after Laparoscopic Radical Prostatectomy. J Urol 2006; 176 (6): 2448-2252.
  38. Permpongkosol S, Link RE, Su LM, Romero FR, Bagga HS, Pavlovich CP, Jarrett TW, Kavoussi LR. Complications of 2,775 Urologic Laparoscopic Procedures: 1993-2005. J Urol 2007; 177(2): 580-85.
  39. Muntener M, Nielsen ME, Romero FR, Schaeffer EM, Allaf ME, Brito FA, Pavlovich CP, Kavoussi LR, Jarrett TW. Long-Term Oncologic Outcome after Laparoscopic Radical Nephroureterectomy for Upper Tract Transitional Cell Carcinoma. Eur Urol 2007; 51(6): 1482-4.
  40. Wagner AA, Link RE, Trock BJ, Sullivan W, Pavlovich CP. Comparison of Open and Laparoscopic Radical Prostatectomy Outcomes from a Surgeon’s Early Experience. Urology 2007; 70(4):667-71.
  41. Muntener M, Schaeffer EM, Romero FR, Nielsen ME, Allaf ME, Brito FA, Pavlovich CP, Kavoussi LR, Jarrett TW. Incidence of local recurrence and port site metastasis after laparoscopic radical nephroureterectomy. Urology 2007; 70(5):864-868.
  42. Yang Y, Padilla-Nash HM, Vira MA, Abu-Asab MS, Val D, Worrell R, Tsokos M, Merino MJ, Pavlovich CP, Ried T, Linehan WM, Vocke CD. The UOK 257 cell line: a novel model for studies of the human Birt-Hogg-Dubé gene pathway. Cancer Genet Cytogenet 2008; 180(2):100-109.
  43. Pavlovich CP, Trock BJ, Sulman A, Wagner AA, Mettee LZ, Su LM. Three Year Actuarial Biochemical Recurrence-Free Survival Following Laparoscopic Radical Prostatectomy: Experience from a Tertiary Referral Center in the United States. J Urol 2008; 179(3): 917-922.
  44. Levinson AW, Pavlovich CP, Ward NT, Link RE, Mettee LZ, Su LM. Association of Surgeon Subjective Characterization of Nerve Sparing Quality with Potency Following Laparoscopic Radical Prostatectomy. J Urol 2008; 179(4):1510-1514.
  45. Levinson AW, Bagga HS, Pavlovich CP, Mettee LZ, Ward NT, Link RE, Su LM. The Impact of Prostate Size on Urinary Quality of Life Indexes Following Laparoscopic Radical Prostatectomy. J Urol 2008; 179(5):1818-1822.
  46. Bivalacqua TJ, Schaeffer EM, Alphs H, Mettee L, Wagner AA, Su LM, Pavlovich CP. Intraperitoneal Effects of Extraperitoneal Laparoscopic Radical Prostatectomy. Urology 2008; 72(2):273-277.
  47. Fujita K, Ewing CM, Sokoll LJ, Elliott DJ, Cunningham M, De Marzo AM, Isaacs WB, Pavlovich CP. Cytokine Profiling of Prostatic Fluid From Cancerous Prostate Glands Identifies Cytokines Associated with Extent of Tumor and Inflammation. Prostate 2008; 68(8):872-882.
  48. Richstone L, Seideman C, Baldinger L, Permpongkosol S, Jarrett TW, Su LM, Pavlovich C, Kavoussi LR. Conversion During Laparoscopic Surgery: Frequency, Indications and Risk Factors. J Urol 2008; 180(3):855-859.
  49. ) Fujita K, Ewing CM, Chan DYS, Mangold LA, Partin AW, Isaacs WB, Pavlovich CP. Endoglin (CD105) as a Urinary and Serum Marker of Prostate Cancer. Int J Cancer 2009; 124(3):664-669.
  50. Guzzo TJ, Allaf ME, Pierorazio PM, Miller D, McNeil BK, Kavoussi LR, Pavlovich CP, Schaeffer EM. Perioperative Outcomes of Elderly Patients Undergoing Laparoscopic Renal Procedures. Urology 2009; 73(3): 572-576.
  51. Guzzo TJ, Schaeffer EM, McNeil BK, Pollock RA, Pavlovich CP, Allaf ME. Laparoscopic radical nephrectomy for patients with pathologic T3b Renal-cell carcinoma: The Johns Hopkins Experience. J Endourol 2009; 23(1): 63-68.
  52. Levinson AW, Ward NT, Sulman A, Mettee LZ, Link RE, Su LM, Pavlovich CP. The impact of prostate size on perioperative outcomes in a large laparoscopic radical prostatectomy series. J Endourol 2009; 23(1): 147-152.
  53. Fujita K, Pavlovich CP, Netto GJ, Konishi Y, Isaacs WB, Ali S, De Marzo A, Meeker AK. Specific detection of prostate cancer cells in urine by multiplex immunofluorescence cytology. Hum Pathol 2009; 40 (7): 924-933.
  54. ) Albadine R, Wang W, Brownlee NA, Toubaji A, Billis A, Argani P, Epstein JI, Garvin AJ, Cousi R, Schaeffer EM, Pavlovich C, Netto GJ. Topoisomerase II alpha Status in Renal Medullary Carcinoma: Immuno-Expression and Gene Copy Alterations of a Potential Target of Therapy. J Urol 2009; 182(2):735-40.
  55. Fujita K, Landis P, McNeil BK, Pavlovich CP. Serial Prostate Biopsies are Associated with an Increased Risk of Erectile Dysfunction. J Urol 2009; 182(6):2664-9.
  56. Fujita K, Ewing CM, Getzenberg RH, Parsons JK, Isaacs WB, Pavlovich CP. Monocyte chemotactic protein-1 (MCP-1/CCL-2) is associated with prostatic growth dysregulation and benign prostatic hyperplasia. Prostate 2010;70(5):473-81.
  57. Schaeffer EM, Guzzo TJ, Furge KA, Netto G, Westphal M, Dykema K, Yang XJ, Zhou M, The BT, Pavlovich CP. Renal medullary carcinoma: Molecular, pathologic and clinical evidence for treatment with topoisomerase inhibiting therapy. BJU Int 2010; 106(1): 62-5.
  58. ) Levinson AW, Ward NT, Sanda MG, Mettee LZ, Wei JT, Su LM, Litwin MS, Pavlovich CP. Comparison of validated instruments measuring sexual function in men. Urology 2010; 76(2): 380-6.
  59. Secin FP, Savage C, Abbou C (list shortened)…, Pavlovich CP, Levinson AW, Touijer KA, Vickers A, Guillonneau B. The learning curve for laparoscopic radical prostatectomy: An international multicenter study. J Urol 2010;184(6):2291-6.
  60. Magheli A, Gonzalgo ML, Su LM, Guzzo TJ, Netto G, Humphreys EB, Han M, Partin AW, Pavlovich CP*: Impact of surgical technique (open vs laparoscopic vs robotic-assisted) on pathological and biochemical outcomes following radical prostatectomy: an analysis using propensity score matching. BJU Int 2011; 107(12): 1956-62.*BJUI Coffey-Krane Award-winning paper
  61. Fujita K, Ewing CM, Isaacs WB, Pavlovich CP. Immunomodulatory IL-18 binding protein is produced by prostate cancer cells and its levels in urine and serum correlate with tumor status. Int J Cancer 2011; 29(2): 424-32.
  62. Levinson AW, Lavery HJ, Ward NT, Su LM, Pavlovich CP: Is a return to baseline sexual function possible? An analysis of sexual function outcomes following laparoscopic radical prostatectomy. World J Urol 2011; 29(1); 29-34.
  63. Ward NT, Parsons JK, Levinson AW, Bagga HS, Mettee LZ, Su LM, Pavlovich CP: Prostate size is not associated with recovery of sexual function after laparoscopic radical prostatectomy. Urology 2011; 77(4): 952-6.
  64. Lin BM, Hyndman ME, Steele KE, Feng Z, Trock BJ, Schweitzer MA, Pavlovich CP: Incidence and Risk Factors for Inguinal and Incisional Hernia After Laparoscopic Radical Prostatectomy. Urology 2011; 77(4): 957-62.
  65. Eifler JB, Levinson AW, Hyndman ME, Trock BJ, Pavlovich CP: Pelvic Lymph Node Dissection is Associated With Symptomatic Venous Thromboembolism Risk During Laparoscopic Radical Prostatectomy. J Urol 2011; 185(5): 1661-65.
  66. Mullins JK, Hyndman ME, Mettee LZ, Pavlovich CP: Comparison of extraperitoneal and transperitoneal pelvic lymph node dissection during minimally invasive radical prostatectomy. J Endourol 2011; 25(12):1883-7.
  67. Albadine R, Hyndman ME, Chaux A, Jeong JY, Saab S, Tavora F, Epstein JI, Gonzalgo ML, Pavlovich CP, Netto GJ: Characteristics of positive surgical margins in robotic-assisted radical prostatectomy, open retropubic radical prostatectomy, and laparoscopic radical prostatectomy: a comparative histopathologic study from a single academic center. Hum Pathol 2012; 43(2):254-60.
  68. Calenda G, Strong TD, Pavlovich CP, Schaeffer EM, Burnett AL, Yu W, Davies KP, Bivalacqua TJ: Whole genome microarray of the major pelvic ganglion after cavernous nerve injury: new insights into molecular profile changes after nerve injury. BJU Int 2012; 109(10); 1552-64.
  69. Pierorazio PM, Ross AE, Lin BM, Epstein JI, Han M, Walsh PC, Partin AW, Pavlovich CP, Schaeffer EM: Preoperative characteristics of high-Gleason disease predictive of favourable pathological and clinical outcomes at radical prostatectomy. BJU Int 2012; 110(8); 1122-8.
  70. Li J, Zhang ZH, Yin CJ, Pavlovich C, Luo J, Getzenberg R, Zhang W: Effect of surgical procedures on prostate tumor gene expression profiles. Asian J Androl 2012; 14(5); 708-714.
  71. Pierorazio PM, Lin BM, Mullins JK, Hyndman ME, Schaeffer EM, Han M, Partin AW, Pavlovich CP: Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomy. Urol Oncol 2013; 31(5);589-94.
  72. Pierorazio PM, Mullins JK, Eifler JB, Voth K, Hyams ES, Han M, Pavlovich CP, Bivalacqua TJ, Partin AW, Allaf ME, Schaeffer EM: Contemporaneous comparison of open vs minimally-invasive radical prostatectomy for high-risk prostate cancer. BJU Int 2013; 112(6) 751-7.
  73. Pierorazio PM, Mullins JK, Ross AE, Hyams ES, Partin AW, Han M, Walsh PC, Schaeffer EM, Pavlovich CP, Allaf ME, Bivalacqua TJ: Trends in immediate perioperative morbidity and delay in discharge after open and minimally invasive radical prostatectomy (RP): a 20-year institutional experience. BJU Int. 2013;112(1):45-53.
  74. Sundi D, Reese AC, Mettee LZ, Trock BJ, Pavlovich CP: Laparoscopic and robotic radical prostatectomy outcomes in obese and extremely obese men. Urology 2013; 82(3), 600-605.
  75. Pavlovich CP, Levinson AW, Su L-M, Mettee LZ, Feng Z, Bivalacqua TJ, Trock BJ: Nightly vs. on-demand sildenafil for penile rehabilitation after minimally-invasive nerve-sparing radical prostatectomy: Results of a randomized double-blind trial with placebo. BJU Int 2013;112(6):844-51.
  76. Kaye DR, Hyndman ME, Segal RL, Mettee LZ, Trock BJ, Feng Z, Su L-M, Bivalacqua TJ, Pavlovich CP: Urinary outcomes are significantly affected by nerve-sparing quality during radical prostatectomy. Urology 2013; 82(6), 1348-54.
  77. Pavlovich CP, Cornish TC, Mullins JK, Fradin J, Mettee LZ, Connor JT, Reese AC, Askin FB, Luck R, Epstein JI, Burke HB: High-resolution transrectal ultrasound: Pilot study of a novel technique for imaging clinically localized prostate cancer. Urol Oncol. 2014; 32(1): 34.e27-32.
  78. Ball MW, Bezerra SM, Gorin MA, Cowan M, Pavlovich CP, Pierorazio PM, Netto GJ, Allaf ME. Grade Heterogeneity in Small Renal Masses: Potential Implications for Renal Mass Biopsy. J Urol. 2014 Jun 21. [Epub ahead of print] PMID:24960470
  79. Reese AC, Johnson PT, Gorin MA, Pierorazio PM, Allaf ME, Fishman EK, Netto GJ, Pavlovich CP: Pathological Characteristics and Radiographic Correlates of Complex Renal Cysts. Urol Oncol. 2014 Jul 8. [Epub ahead of print] PMID:25022857
  80. Ball MW, Reese AC, Mettee L, Pavlovich C: Safety of Minimally Invasive Radical Prostatectomy in Patients with Prior Abdominopelvic or Inguinal Surgery. J Endourol. 2014 Aug 19. [Epub ahead of print] PMID: 25137522

Invited Review Articles:

  1. Pavlovich CP, Schlegel PN: Cost-effectiveness of treatments for male infertility: A review. Asst Repr Rev 1998; 8 (1): 40-46.
  2. Phillips JL, Pavlovich CP, Walther MM, Ried T, Linehan WM: The genetic basis of renal epithelial tumors: advances in research and its impact on prognosis and therapy. Curr Opin Urol 2001; 11(5): 463-469.
  3. Pavlovich CP, Schmidt LS, Phillips JL: The genetic basis of renal cell carcinoma. Urol Clin N America, Aug 2003; 30(3):437-54.
  4. Pavlovich CP, Schmidt LS: Searching for the hereditary causes of renal-cell carcinoma. Nat Rev Cancer 2004; 4(5): 381-93.
  5. Pavlovich CP: Clinical Practice Point - "Does preservation of the neurovascular bundle affect surgical outcome in men with prostate cancer?" Nat Clin Pract Urol 2005; 2(3):124-5.
  6. Hyndman ME, Mullins JK, Pavlovich CP: Pelvic node dissection in prostate cancer: extended, limited, or not at all? Curr Opin Urol. 2010; 20(3):211-7

Editorials:

  1. Pavlovich CP, Battiwalla M, Rick ME, Walther MM. Antibody induced coagulopathy from bovine thrombin use during partial nephrectomy. J Urol 2001; 165: 1617.
  2. Leach FS, Gutierrez ME, Pavlovich CP, Wilson WH. Lymphoma of the kidney; a case of mistaken identity, Infections in Urology 2001; 14(2), 46-48.
  3. Wood BJ, Grippo J, Pavlovich CP. Percutaneous radiofrequency ablation for hematuria. J Urol 2001; 166: 2303-2304.
  4. Ong AM, Bhayani SB, Pavlovich CP. Trocar Site Recurrence After Laparoscopic Nephroureterectomy. J Urol 2003; 170(4):1301.
  5. Rogers CG, Epstein JI, Pavlovich CP. Adenofibroma of the testis discovered at exploration for torsion after trauma. J Urol 2003; 170(5): 1943.
  6. Margreiter M, Hernandez DJ, Lang EK, Pavlovich CP. Horseshoe Kidney with Giant Hydronephrosis secondary to Ureteropelvic Junction (UPJ) Obstruction. J Urol 2010;183(1):329.
  7. Gupta AD, Semins MJ, Marx JK, Pavlovich CP. Renal Artery Pseudoaneurysm After Partial Nephrectomy. J Urol 2010; 183(6):2390-1.

Case Reports:

  1. Pavlovich CP, Battiwalla M, Rick ME, Walther MM. Antibody induced coagulopathy from bovine thrombin use during partial nephrectomy. J Urol 2001; 165: 1617.

  2. Leach FS, Gutierrez ME, Pavlovich CP, Wilson WH. Lymphoma of the kidney; a case of mistaken identity, Infections in Urology 2001; 14(2), 46-48.

  3. Wood BJ, Grippo J, Pavlovich CP. Percutaneous radiofrequency ablation for hematuria. J Urol 2001; 166: 2303-2304.

  4. Ong AM, Bhayani SB, Pavlovich CP. Trocar Site Recurrence After Laparoscopic Nephroureterectomy. J Urol 2003; 170(4):1301.

  5. Rogers CG, Epstein JI, Pavlovich CP. Adenofibroma of the testis discovered at exploration for torsion after trauma. J Urol 2003; 170(5): 1943.

  6. Margreiter M, Hernandez DJ, Lang EK, Pavlovich CP. Horseshoe Kidney with Giant Hydronephrosis secondary to Ureteropelvic Junction (UPJ) Obstruction. J Urol in press.

Letters, correspondence:

  1. Pavlovich CP, Pitts WR Jr: (Letter) Re: Osteoporosis after orchiectomy for prostate cancer. J Urol 1999; 162 (4): 1392.
  2. Pavlovich, CP: Guided energy treatments for renal tumor ablation. October, 2000. AUA News.
  3. Levinson AW, Ward NT, Pavlovich CP: (Letter) Re: Defining potency: a comparison of the International Index of erectile Function short version and the Expanded Prostate Cancer Index Composite. Cancer 2009; 115(23): 5608.

Book chapters, Monographs:

  1. Pavlovich CP, Schlegel PN: Male infertility – Current treatments, costs, and effectiveness, AUA Update Series 1999, Volume XVIII, Lesson 22.
  2. Pavlovich CP, Linehan WM, Walther MM: Partial Adrenalectomy in Patients with Multiple Adrenal Tumors, Curr Urol Rep 2001; 2(1); 19-23.
  3. Pavlovich CP, Walther MM: Partial Adrenalectomy: Indications and Technique. In Renal and Adrenal Tumors – Biology and Management, Eds. A. Belldegrun and E.D. Vaughan, Jr., Oxford University Press, Oxford, England, 2003: Chapter 58, 581-584.
  4. Pavlovich CP and others: "Familial Renal Cell Carcinoma" chapter in WHO Classification of Tumours -Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs", 2004. Eds. Eble, Sauter, Epstein, Sesterhenn. IARC Press, Lyon, France.
  5. Pavlovich CP, Schmidt L: "Hereditary Syndromes of Renal Cell Carcinoma" chapter in "Cancer Hereditario" textbook (Spanish), 2006. Sociedad Espanola de Oncologica Medica (SEOM) (www.seom.org). pp. 531-562. Updated, 2010.
  6. Wagner AA, Pavlovich CP: "Laparoscopic Radical Cystectomy and Urinary Diversion", chapter 25 in "Atlas of Laparoscopic Urologic Surgery", 2007. Eds. J. Bishoff and L.R. Kavoussi: Saunders, Philadelphia, pp. 282-296.
  7. Pavlovich CP and Reese AC: Chapter 6 - "Robot-assisted radical prostatectomy: A surgical guide to the extraperitoneal approach" in "Radical Prostatectomy: Surgical Perspectives", 2014. Eds. J. Eastham and E.M. Schaeffer: Springer, New York, pp. 89-105.
  8. Pavlovich CP, Gorin MA, Pierorazio PM, Mullins JK: "Pelvic lymphadenectomy for prostate and bladder cancer" chapter in "Pelvic Cancer Surgery: Modern Breakthroughs and Future Advances", 2014. Eds Patel H, Mould T, Joseph J, Delaney C.: New York, Springer-Verlag.

Other media:

  1. Video: "Nerve-sparing During Laparoscopic Radical Prostatectomy: Adhering to the High Standard of Open Surgery" by Link RE, Pavlovich CP, Bhayani SB, Sullivan W, and Su L-M. Presented at American Urological Association Annual Meeting, 2004.

MEMBERSHIP IN PROFESSIONAL ORGANIZATIONS

  • American Medical Association

  • American Urological Association

  • Society of Urologic Oncology

  • Society of Endourology

  • Mid-Atlantic Section, American Urological Association

BOARD OF DIRECTORS

  • Mid-Atlantic Section, American Urological Association 2013-2016

AWARDS & HONORS

    2006

    Urology Teaching Award, Brady Urological Institute, Johns Hopkins Medical Institutions

    2004 First Prize: Ambrose-Reed Socioeconomics Essay Contest - "Making ends
    meet: a cost comparison of laparoscopic and open radical retropubic
    prostatectomy" essay, American Urological Association.
    2004 First Prize: Video Contest: "Nerve-sparing Laparoscopic Radical
    Prostatectomy" video, American Urological Association.
    1999 - 2001 Loan Repayment, National Institutes of Health.
    1999 - 2001 Fellowship, National Institutes of Health Urologic Oncology Branch,
    American Foundation of Urologic Disease (A.F.U.D.).
    1999 Pfizer Scholar in Urology.
    1999 Outstanding Presentation, Society of University Urology Residents.
    1999 Distinguished Housestaff Award, New York Presbyterian Hospital * Cornell
    Medical Center.
    1998 First Prize: AUA Ambrose-Reed Socioeconomics Essay Contest - "A cost
    analysis of treatment options for male infertility" essay, American Urological
    Association.
    1997 Yamanouchi Prize for Urology Resident Research.
    1993 Alpha Omega Alpha Honor Medical Society.
    1992-93 Continuing Scholarship Award, Howard Hughes Medical Institute (HHMI).
    1991-92 Research Scholarship, Immunology, HHMI * National Institutes of Health.
    1987-1988 Fulbright * Swiss Universities Fellowship to study Molecular Biology.
    1984 - 1987 Harvard National Scholarship.
    1984-87 Harvard College Scholarship
    1984 National Presidential Scholar.

     

PATENTS

Provisional Patent Filed 04/09. JHU Ref. No. C-10673. Title: “Benign Prostatic Hyperplasia (BPH) and Lower Urinary Tract Symptoms (LUTS) Biomarker and Therapy” Investigators: Dr. Christian P. Pavlovich, Dr. Kazutoshi Fujita, Dr. J. Kellogg Parsons.

   CONTACT INFORMATION

 

  • Address:
    Brady Urological Institute,
    Johns Hopkins Bayview Medical Center,
    301 Building, Suite 3100,
    4940 Eastern Avenue, Baltimore, MD 21224
  • Appointments: 410-550-7008
  • Office: 410 550-0013
  • Fax: (410) 550-4188




© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.| Disclaimer
Email: webmaster@urology.jhu.edu | 600 North Wolfe Street, Baltimore, Maryland 21287